Analysis of clinical, dosimetric and radiomic features for predicting local failure after stereotactic radiotherapy of brain metastases in malignant melanoma
Authors:
Nanna E. Hartong,
Ilias Sachpazidis,
Oliver Blanck,
Lucas Etzel,
Jan C. Peeken,
Stephanie E. Combs,
Horst Urbach,
Maxim Zaitsev,
Dimos Baltas,
Ilinca Popp,
Anca-Ligia Grosu,
Tobias Fechter
Abstract:
Background: This study aimed to predict lesion-specific outcomes after stereotactic radiotherapy (SRT) in patients with brain metastases from malignant melanoma (MBM), using clinical, dosimetric pretherapeutic MRI data. Methods: In this multicenter retrospective study, 517 MBM from 130 patients treated with single-fraction or hypofractionated SRT across three centers were analyzed. From contrast-e…
▽ More
Background: This study aimed to predict lesion-specific outcomes after stereotactic radiotherapy (SRT) in patients with brain metastases from malignant melanoma (MBM), using clinical, dosimetric pretherapeutic MRI data. Methods: In this multicenter retrospective study, 517 MBM from 130 patients treated with single-fraction or hypofractionated SRT across three centers were analyzed. From contrast-enhanced T1-weighted MRI, 1576 radiomic features (RF) were extracted per lesion - 788 from the gross tumor volume (GTV), 788 from a 3 mm peritumoral margin. Clinical data, radiation dose and RF from one center were used for feature selection and model development via nested cross-validation; external validation was performed using the other two centers. Results: Local failure occurred in 72 of 517 lesions (13.9%). Predictive models based on clinical data (model 1), RF (model 2), or both (model 3) achieved c-indices of 0.60 +/- 0.15, 0.65 +/- 0.11, and 0.65 +/- 0.12. RF-based models outperformed the clinical model, while dosimetric data alone were not predictive. Most predictive RF came from the peritumoral margin (92%) vs. GTV (76%). On the first external dataset, all models performed similarly (c-index: 0.60-0.63), but showed poor generalization on the second (c-index < 0.50), likely due to differences in patient characteristics and imaging protocols. Conclusions: Information extracted from pretherapeutic MRI, particularly from the peritumoral area, can support accurate prediction of lesion-specific outcomes after SRT in MBM. When combined with clinical data, these imaging-derived markers offer valuable prognostic insights. However, generalizability remains challenging by heterogeneity in patient populations and MRI protocols.
△ Less
Submitted 22 May, 2025; v1 submitted 31 May, 2024;
originally announced May 2024.
Study of cost functionals for ptychographic phase retrieval to improve the robustness against noise, and a proposal for another noise-robust ptychographic phase retrieval scheme
Authors:
A. P. Konijnenberg,
W. M. J. Coene,
H. P. Urbach
Abstract:
Recently, efforts have been made to improve ptychography phase retrieval algorithms so that they are more robust against noise. Often the algorithm is adapted by changing the cost functional that needs to be minimized. In particular, it has been suggested that the cost functional should be obtained using a maximum-likelihood approach that takes the noise statistics into account. Here, we consider…
▽ More
Recently, efforts have been made to improve ptychography phase retrieval algorithms so that they are more robust against noise. Often the algorithm is adapted by changing the cost functional that needs to be minimized. In particular, it has been suggested that the cost functional should be obtained using a maximum-likelihood approach that takes the noise statistics into account. Here, we consider the different choices of cost functional, and to how they affect the reconstruction results. We find that seemingly the only consistently reliable way to improve reconstruction results in the presence of noise is to reduce the step size of the update function. In addition, a noise-robust ptychographic reconstruction method has been proposed that relies on adapting the intensity constraints
△ Less
Submitted 31 March, 2017;
originally announced March 2017.